Skip to content
buyWeak

Steve Elms bought $217k of ADMA

director at ADMA BIOLOGICS, INC.. 14,000 shares at an average of $15.53, traded Mar 5, 2026, filed Mar 9, 2026.

Conviction score
30
Value
$217k
14,000 shares
Holdings after
2,045,730
+1% from before
From 52-week low
+12%
low $13.99, close $15.70
From 52-week high
-36%
high $24.51, as of Mar 5, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $217k at market
    +12
  • Relative to holdings
    Under 1% of holdings (0.7%)
    -5
  • Price context
    36% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -37.8%, 3m -49.0%, 6m -39.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ADMAOct 13, 2026 · close 10.31
Since filing Mar 9, 2026: -34.8%SPY +15.6% · excess -50.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001140361-26-008363, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 5, 2026POpen-market purchase
Common Stockindirect: See footnote
+7,000$15.67$110k2,038,730Mar 9, 2026
Mar 6, 2026POpen-market purchase
Common Stockindirect: See footnote
+7,000$15.39$108k2,045,730Mar 9, 2026

Related signals

Other insiders at ADMA BIOLOGICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
45Moderate
ADMAbuy
ADMA BIOLOGICS, INC.
Jerrold B Grossman
director
$51k
6,400 shares
+1%
48Moderate
ADMAbuy
ADMA BIOLOGICS, INC.
Jerrold B Grossman
director
$100k
12,500 shares
+2%
43Moderate
ADMAbuy
ADMA BIOLOGICS, INC.
Jerrold B Grossman
director
$100k
12,500 shares
+3%
12Weak
ADMAsell 210b5-1
ADMA BIOLOGICS, INC.
Adam S Grossman
President and CEO
$318k
21,000 shares
-1%
24Weak
ADMAsell 2
ADMA BIOLOGICS, INC.
Kaitlin M. Kestenberg-Messina
COO and SVP, Compliance
$158k
10,096 shares
-2%
5Weak
ADMAsell10b5-1
ADMA BIOLOGICS, INC.
Adam S Grossman
President and CEO
$338k
21,000 shares
-1%
6Weak
ADMAsell10b5-1
ADMA BIOLOGICS, INC.
Adam S Grossman
President and CEO
$416k
21,000 shares
-1%
5Weak
ADMAsell10b5-1
ADMA BIOLOGICS, INC.
Adam S Grossman
President and CEO
$336k
21,000 shares
-1%
5Weak
ADMAsell10b5-1
ADMA BIOLOGICS, INC.
Adam S Grossman
President and CEO
$336k
21,000 shares
-1%
5Weak
ADMAsell10b5-1
ADMA BIOLOGICS, INC.
Adam S Grossman
President and CEO
$339k
21,000 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Steve Elms bought $217k of ADMA | InsiderTell